SCM

Stonepine Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 70.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$231M
AUM Growth
-$69.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
23
New
Increased
Reduced
Closed

Top Buys

1
+$1.38M
2
+$438K
3
+$53.3K
4
XERS icon
Xeris Biopharma Holdings
XERS
+$39.9K
5
AYTU icon
AYTU BioPharma
AYTU
+$275

Top Sells

1
+$19.9M
2
+$14.1M
3
+$11.7M
4
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
+$8.2M
5
XFOR icon
X4 Pharmaceuticals
XFOR
+$5.75M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$56.2M 24.29%
5,333,004
+154,000
2
$41.7M 18.03%
9,222,617
+118,342
3
$36.8M 15.92%
2,500,000
-15,868
4
$33.2M 14.34%
450,000
-208,794
5
$17.3M 7.47%
3,999,459
+15,773
6
$14M 6.03%
5,937,000
+21,628
7
$10.6M 4.6%
261,870
-540,674
8
$4.63M 2%
250,000
-186,602
9
$3.13M 1.35%
1,666,037
-309,271
10
$3.02M 1.31%
1,355,186
-1,497,413
11
$2.75M 1.19%
2,768,656
-303,820
12
$2.56M 1.11%
839,514
-880,486
13
$2.1M 0.91%
317,782
-174,137
14
$1.34M 0.58%
472,469
+100
15
$1.33M 0.58%
669,684
-533,807
16
$680K 0.29%
482,258
-4,144,366
17
– –
-63,413
18
– –
-686,240
19
– –
-3,339,405
20
– –
-3,761,640
21
– –
-477,903
22
– –
-175,790
23
– –
-7,965,865